Tikkanen, Ilkka
University of Helsinki · Helsinki University Hospital
3 papers on CoChatORCID 0000-0001-8519-9722
Most cited papers
- Verified
Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension
Tikkanen, I., Narko, K., Zeller, C., Green, A., Salsali, A., Broedl, U. C., & Woerle, H. J. (2015) · Diabetes Care
Blood Pressure and Hypertension StudiesDiabetes Treatment and Management
Cited by 468
- Verified
Pooled analysis of Phase III trials indicate contrasting influences of renal function on blood pressure, body weight, and HbA1c reductions with empagliflozin
Cherney, D. Z. I., Cooper, M. E., Tikkanen, I., Pfarr, E., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Lund, S. S. (2018) · Kidney International
Diabetes Treatment and ManagementBlood Pressure and Hypertension Studies
Cited by 243
- Verified
Impact of empagliflozin on blood pressure in patients with type 2 diabetes mellitus and hypertension by background antihypertensive medication
Mancia, G., Cannon, C. P., Tikkanen, I., Zeller, C., Ley, L., Woerle, H. J., Broedl, U. C., & Johansen, O. E. (2016) · Hypertension
Blood Pressure and Hypertension StudiesDiabetes Treatment and Management
Cited by 128
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free